Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
6
×
life sciences
medicare
national blog main
wisconsin blog main
wisconsin top stories
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
drug prices
eli lilly
novartis
aduro biotech
alzheimer's disease
biogen
bristol-myers squibb
cancer immunotherapy
celgene
deals
democrats
What
price
6
×
bio
companies
drug
plan
public
roundup
year
according
adversity
airport
alzheimer’s
annual
answer
apocalypse
approval
away
based
beats
beds
biogen’s
biopharmaceutical
celgene
clinical
cold
company
convo
days
dealing
deb
debuted
democratic
dems
developing
different
discontent
discussed
drugs
earlier
early
Language
unset
Current search:
price
×
biotech
×
@techcrunch.com
2 years ago
Rani Therapeutics’ $73M IPO will fund upcoming clinical trials
@xconomy.com
4 years ago
Pelosi, Dems Unveil Price Plan: Are 25 Drugs Enough for Negotiation?
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More
@xconomy.com
6 years ago
Exact Sciences Beats Quarterly Forecasts, Sending Its Stock Price Up